Abstract
Chronic nonbacterial prostatitis, or urological chronic pelvic pain syndrome (UCPPS), remains a common and often challenging disorder to evaluate and treat. Employing a more holistic approach, including urological therapy, physical therapy, and psychosocial perspectives, may be more appropriate for most patients. Growing evidence supports the use of biofeedback, myofascial trigger point release, prescribed exercise regimens, relaxation techniques, and supportive counseling to treat men with UCPPS.
Similar content being viewed by others
References and Recommended Reading
Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al.: The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999, 2: 369–375.
Shoskes DA, Landis JR, Wang Y, et al.: Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome. J Urol 2004, 172: 542–547.
Sadeghi-Nejad H, Seftel A: Sexual dysfunction and prostatitis. Curr Urol Rep 2006, 7: 479–484.
Collins MM, Stafford RS, O’Leary MP, Barry MJ: How common is prostatitis? A national survey of physician visits. J Urol 1998, 159: 1224–1228.
Krieger JN, Lee SW, Jeon J, et al.: Epidemiology of prostatitis. Int J Antimicrob Agents 2008, 31(Suppl 1): S85–S90.
Aoki Y, Kao PN: Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. Antimicrob Agents Chemother 1999, 43: 2678–2684.
Galley HF, Nelson SJ, Dubbels AM, Webster NR: Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis. Crit Care Med 1997, 25: 1392–1395.
Mishra VC, Browne J, Emberton M: Role of alpha-blockers in type III prostatitis: a systematic review of the literature. J Urol 2007, 177: 25–30.
Nickel JC, Krieger JN, McNaughton-Collins M, et al.: Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med 2008, 359: 2663–2673.
Nickel JC, Downey J, Pontari MA, et al.: A randomized placebo-controlled multicenter study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int 2004, 93: 991–995.
Kaplan SA, Volpe MA, Te AE: A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol 2004, 171: 284–288.
Prahalada S, Tarantal AF, Harris GS, et al.: Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta). Teratology 1997, 55: 119–131.
Nickel JC, Downie J, Arden D: Failure of a monotherapy for difficult chronic prostatitis/chronic pelvic pain syndrome. J Urol 2004, 172: 551–554.
Clemens JQ, Nadler RB, Schaeffer AJ, et al.: Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology 2000, 56: 951–955.
Cornel EB, van Haarst EP, Schaarsberg RW, Geels J: The effect of biofeedback physical therapy in men with chronic pelvic pain syndrome type III. Euro Urol 2005, 47: 607–611.
Weiss JM: Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol 2001, 166: 2226–2231.
Anderson RU, Wise D, Sawyer T, Chan C: Integration of myofascial trigger point release and paradoxical relation training treatment of chronic pelvic pain in men. J Urol 2005, 174: 155–160.
Fitzgerald M, Anderson R, Potts J, et al.: UPPCRN: Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urologic chronic pelvic pain syndromes. J Urol 2009 (in press).
Benjamin PJ, Tappan FM: Tappan’s Handbook of Healing Massage Techniques: Classic, Holistic, and Emerging Methods. Upper Saddle River, NJ: Pearson Education, Inc.; 2005.
Potts J: Physical therapy for CP/CPPS. In Prostatitis. Edited by Shoskes DA. New York: Humana Press; 2008.
Travell JG, Simons DG: Myofascial Pain and Dysfunction: The Trigger Point Manual. Baltimore: Williams and Wilkins; 1983.
Potts JM, O’Dougherty E: Pelvic floor physical therapy for patients with prostatitis. Cur Urol Rep 2000, 1: 155–158.
Kotarinos RK: CP/CPPS Pelvic Floor Dysfunction: Evaluation and Treatment. New York: Humana Press; 2007.
Berghuis JP, Heiman JR, Rothman I, Berger RE: Psychological and physical factors involved in chronic idiopathic prostatitis. J Psychosom Res 1996, 41: 313–325.
Mehik A, Hellstrom P, Sarpola A, et al.: Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland. BJU Int 2001, 88: 35–38.
Clemens JQ, Brown SO, Calhoun EA: Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J Urol 2008, 180: 1378–1382.
Tripp DA, Nickel JC, Wang Y, et al.: Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome. J Pain 2006, 7: 697–708.
Ullrich PM, Turner JA, Ciol M, Berger R: Stress is associated with subsequent pain and disability among men with nonbacterial prostatitis/pelvic pain. Ann Behav Med 2005, 30: 112–118.
Anderson RU, Orenberg EK, Chan CA, et al.: Psychometric profiles and hypothalamic-pituitary-adrenal axis function in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol 2008, 179: 956–960.
Wise D, Anderson R: A Headache in the Pelvis. Occidental, CA: National Center for Pelvic Pain Research; 2003.
Miller HC: Stress prostatitis. Urology 1988, 32: 507–510.
Kellner R: Psychosomatic syndromes, somatization and somatoform disorders. Psychother Psychosom 1994, 61: 4–24.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Potts, J.M. Nonpharmacological approaches for the treatment of urological chronic pelvic pain syndromes in men. Curr Urol Rep 10, 289–294 (2009). https://doi.org/10.1007/s11934-009-0047-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11934-009-0047-2